Amylyx’s ALS Drug Should Wait For Phase III Results, US FDA Panel Says

 
• By Sue Sutter
Bird on one leg
This bird may be able to stand on one leg, but Amylyx's ALS drug cannot, an FDA committee said. • Source: Alamy

More from US FDA Performance Tracker

More from Regulatory Trackers